COMPENDIUM ON FUNCTIONAL MEDICINE - Flipbook - Page 792
[90] Mazier W, Le Roy T, Soulard P, et al. A new strain of
Christensenella minuta as a potential biotherapy for obesity and
associated metabolic diseases. Cells. 2021;10(4):823.
[91] Akbuğa-Schön T, Suzuki TA, Jakob D, et al. The keystone gut
species Christensenella minuta boosts gut microbial biomass and
voluntary physical activity in mice. mBio. 2024;15(2).
[92] Ang WS, Law JW, Letchumanan V, et al. A keystone gut
bacterium Christensenella minuta-a potential biotherapeutic
agent for obesity and associated metabolic diseases. Foods.
2023;12(13):2485.
[93] Kropp C, Le Corf K, Relizani K, et al. The keystone commensal
bacterium Christensenella minuta DSM 22607 displays
anti-inflammatory properties both in vitro and in vivo. Sci Rep.
2021;11(1):11494.
[94] Kim YG, Sakamoto K, Seo SU, et al. Neonatal acquisition of
Clostridia species protects against colonization by bacterial
pathogens. Science. 2017;356(6335):315-319.
[95] Ju T, Kong JY, Stothard P, et al. Defining the role of
Parasutterella, a previously uncharacterized member of the core
gut microbiota. ISME J. 2019;13(6):1520-1534.
[96] Dalile B, Van Oudenhove L, Vervliet B, et al. The role of
short-chain fatty acids in microbiota-gut-brain communication.
Nat Rev Gastroenterol Hepatol. 2019;16(8):461-478.
[97] Zhao L, Zhang F, Ding X, et al. Gut bacteria selectively
promoted by dietary fibers alleviate type 2 diabetes. Science.
2018;359(6380):1151-1156.
[98] Devlin AS, Fischbach MA. A biosynthetic pathway for a
prominent class of microbiota-derived bile acids. Nat Chem Biol.
2015;11(9):685-90.
792